3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is increasingly attracting scientific attention due to initial data suggesting different pharmacological characteristics. Present studies suggest that 3-HPC may exhibit distinct impacts on the brain system, potentially influencing to some of the unexplained symptoms related with P